These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients. Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ; Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234 [TBL] [Abstract][Full Text] [Related]
9. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis. Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110 [TBL] [Abstract][Full Text] [Related]
10. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement. Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717 [TBL] [Abstract][Full Text] [Related]
11. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator. Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269 [TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes in Patients with Severe Renal Dysfunction Including Dialysis Following Defibrillator Implantation. Bogdan S; Nof E; Eisen A; Sela R; Rosenheck S; Freedberg N; Geist M; Ben-Zvi S; Haim M; Glikson M; Goldenberg I; Suleiman M; Am J Nephrol; 2015; 42(4):295-304. PubMed ID: 26529418 [TBL] [Abstract][Full Text] [Related]
14. Risk of death without appropriate defibrillator shock in patients with advanced renal dysfunction. Goldenberg I; Mor T; Nof E; Younis A; Berkovitch A; Rosso R; Barsheshet A; Suleiman M; Beinart R Europace; 2019 Mar; 21(3):459-464. PubMed ID: 30689821 [TBL] [Abstract][Full Text] [Related]
15. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort. Heidbuchel H; Willems R; Jordaens L; Olshansky B; Carre F; Lozano IF; Wilhelm M; Müssigbrodt A; Huybrechts W; Morgan J; Anfinsen OG; Prior D; Mont L; Mairesse GH; Boveda S; Duru F; Kautzner J; Viskin S; Geelen P; Cygankiewicz I; Hoffmann E; Vandenberghe K; Cannom D; Lampert R Eur J Prev Cardiol; 2019 May; 26(7):764-775. PubMed ID: 30813818 [TBL] [Abstract][Full Text] [Related]
16. Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System. Gold MR; El-Chami MF; Burke MC; Upadhyay GA; Niebauer MJ; Prutkin JM; Herre JM; Kutalek S; Dinerman JL; Knight BP; Leigh J; Lucas L; Carter N; Brisben AJ; Aasbo JD; Weiss R; J Am Coll Cardiol; 2023 Aug; 82(5):383-397. PubMed ID: 37495274 [TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications. Olde Nordkamp LR; Postema PG; Knops RE; van Dijk N; Limpens J; Wilde AA; de Groot JR Heart Rhythm; 2016 Feb; 13(2):443-54. PubMed ID: 26385533 [TBL] [Abstract][Full Text] [Related]
18. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry. Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery. Mesquita J; Cavaco D; Ferreira A; Lopes N; Santos PG; Carvalho MS; Haas A; Costa F; Carmo P; Morgado F; Adragão P; Mendes M Int J Cardiol; 2017 Apr; 232():176-180. PubMed ID: 28082086 [TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry. Steiner H; Geist M; Goldenberg I; Suleiman M; Glikson M; Tenenbaum A; Swissa M; Fisman EZ; Golovchiner G; Strasberg B; Barsheshet A; Cardiovasc Diabetol; 2016 Dec; 15(1):160. PubMed ID: 27905927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]